Integra LifeSciences names Mojdeh Poul as President & CEO effective Jan 6, 2025

INTEGRA LIFESCIENCES HOLDINGS CORP

Mojdeh Poul appointed President & CEO, effective January 6, 2025, succeeding Jan De Witte.
Poul previously EVP & Group President of 3M's $8.5B global healthcare business.
Poul to receive base salary of $1.05M, target bonus 125%, and initial equity awards totaling $6.75M.
Jan De Witte's resignation is part of a previously announced succession plan; no disagreement.
Stuart Essig to remain Executive Chairman temporarily before returning to non-executive role.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mojdeh Poul

President and Chief Executive Officer

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Effective: 2025-01-06
Filed: November 4, 2024, 6:59 PM ET

On November 4, 2024, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Mojdeh Poul to serve as its President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mojdeh Poul was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On November 4, 2024, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Mojdeh Poul to serve as its President and Chief Executive Officer.

View on SEC.gov

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-24-000105

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.